Avantor, Inc. (NYSE:AVTR) Receives $27.69 Consensus Target Price from Analysts

Avantor, Inc. (NYSE:AVTR) has received an average recommendation of “Moderate Buy” from the thirteen brokerages that are presently covering the stock, Marketbeat.com reports. Two investment analysts have rated the stock with a hold recommendation and eleven have issued a buy recommendation on the company. The average 12 month price objective among brokerages that have updated their coverage on the stock in the last year is $27.69.

A number of research firms have recently weighed in on AVTR. Wells Fargo & Company cut their price objective on shares of Avantor from $30.00 to $28.00 and set an “overweight” rating for the company in a research report on Monday, October 28th. Robert W. Baird reduced their price target on Avantor from $27.00 to $26.00 and set an “outperform” rating on the stock in a research note on Monday, October 28th. UBS Group lowered their price objective on Avantor from $30.00 to $29.00 and set a “buy” rating for the company in a research report on Tuesday, October 8th. Royal Bank of Canada reiterated an “outperform” rating and set a $34.00 target price on shares of Avantor in a research report on Thursday, September 26th. Finally, Barclays lowered their price target on Avantor from $28.00 to $25.00 and set an “overweight” rating for the company in a report on Friday, October 25th.

Institutional Trading of Avantor

A number of institutional investors have recently added to or reduced their stakes in AVTR. UMB Bank n.a. acquired a new position in shares of Avantor during the third quarter worth about $49,000. Nisa Investment Advisors LLC lifted its position in Avantor by 69.6% during the 3rd quarter. Nisa Investment Advisors LLC now owns 2,035 shares of the company’s stock worth $53,000 after acquiring an additional 835 shares in the last quarter. GAMMA Investing LLC boosted its holdings in Avantor by 89.9% in the 3rd quarter. GAMMA Investing LLC now owns 2,715 shares of the company’s stock worth $70,000 after acquiring an additional 1,285 shares during the period. Livforsakringsbolaget Skandia Omsesidigt grew its position in Avantor by 278.0% in the third quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 5,031 shares of the company’s stock valued at $130,000 after acquiring an additional 3,700 shares in the last quarter. Finally, ORG Wealth Partners LLC purchased a new stake in shares of Avantor during the third quarter valued at approximately $139,000. 95.08% of the stock is owned by hedge funds and other institutional investors.

Avantor Trading Down 0.0 %

Shares of AVTR stock opened at $21.07 on Thursday. The company has a market capitalization of $14.34 billion, a price-to-earnings ratio of 45.80, a PEG ratio of 2.75 and a beta of 1.29. The company has a current ratio of 1.54, a quick ratio of 1.06 and a debt-to-equity ratio of 0.84. The firm has a 50-day moving average price of $21.63 and a 200 day moving average price of $23.34. Avantor has a twelve month low of $19.59 and a twelve month high of $28.00.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.